7-144129372-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001659.3(OR2A14):c.260A>T(p.Gln87Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001659.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2A14 | NM_001001659.3 | c.260A>T | p.Gln87Leu | missense_variant | 2/2 | ENST00000641068.1 | NP_001001659.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2A14 | ENST00000641068.1 | c.260A>T | p.Gln87Leu | missense_variant | 2/2 | NM_001001659.3 | ENSP00000493353 | P1 | ||
OR2A14 | ENST00000408899.2 | c.260A>T | p.Gln87Leu | missense_variant | 1/1 | ENSP00000386137 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249410Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135298
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461880Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727238
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 19, 2023 | The c.260A>T (p.Q87L) alteration is located in exon 1 (coding exon 1) of the OR2A14 gene. This alteration results from a A to T substitution at nucleotide position 260, causing the glutamine (Q) at amino acid position 87 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at